Dresner Partners Research
Advisory Approach and Market Positioning
Founded in 1991 by Steven M. Dresner, Dresner Partners emerged from a clear market insight: while Wall Street's investment banking capacity focused exclusively on multibillion-dollar mega-deals, thousands of middle-market businesses with enterprise values between $5M and $500M were underserved. Dresner's thesis is straightforward but powerful—middle-market companies deserve the same institutional-quality advisory, extensive buyer networks, and execution rigor that larger corporations receive. Over 30+ years, Dresner has built a reputation as the preferred sell-side advisor for entrepreneurs, family offices, and private equity sponsors seeking to maximize value through thoughtful, process-driven transactions.
Dresner Partners is an independent advisory firm without conflicts of interest from proprietary trading, debt underwriting, or equity positions. This independence allows the firm to serve clients with complete objectivity, working for the seller rather than optimizing for any particular transaction structure. The firm's business model emphasizes senior banker involvement—unlike larger banks where managing directors oversee multiple simultaneous engagements, Dresner ensures that senior partners provide day-to-day leadership on all transactions.
Sector and Industry Focus
Dresner's core expertise spans multiple high-value sectors, with particular depth in healthcare, consumer products, industrials, and business services.
Healthcare is a cornerstone vertical. Dresner has established itself as the leading M&A advisor in the fertility and IVF sector, having closed dozens of high-profile transactions. Recent deals include New England Fertility Institute's sale to CSG.Bio, Advanced Fertility's sale to Prelude Fertility, Dominion Fertility's sale to Webster Equity Partners, Reproductive Science Center of New Jersey's partnership with The Prelude Network, and RMA NJ's merger with IVI of Spain. Beyond fertility, Dresner advises across healthcare services more broadly, including physician practices (ENT, otolaryngology), ambulatory surgery centers, dialysis centers, skilled nursing facilities, and hospital system divestitures. The firm has closed 20+ healthcare transactions in recent years, with particular expertise in healthcare services consolidation, where multiple independent practices merge under common management to achieve scale.
Consumer Products is a specialty. Dresner recently advised Connoisseurs Products—the world's leading jewelry cleaner brand founded in 1959—on its sale to Willert Home Products. The firm has extensive experience advising branded consumer goods manufacturers, specialty retailers, and household products companies. Dresner understands the valuation challenges unique to consumer products: brand strength, distribution relationships with major retailers (big-box and specialty), manufacturing economics, and buyer universe composition (strategic acquirers in larger CPG firms, PE firms seeking consumer platforms, and family offices building portfolios).
Industrials and Materials. Dresner's industrials practice covers manufacturing, materials processing, aerospace components, and specialty metals. A recent transaction exemplifies the firm's reach: advising CAI Custom Alloys (vacuum-melt certified aerospace materials processor) on its sale to EverMetal Holdings, a critical metals recycling platform backed by GEF Capital Partners. Dresner also advised on Sandin Manufacturing's sale to MultiTech Industries.
Business Services. The firm has deep experience advising staffing firms, IT consulting practices, marketing services, and professional services consolidations. Dresner understands the human-capital-intensive nature of these businesses and connects sellers with buyers who value talent retention and cultural fit.
Technology and IT Services. Dresner has capabilities in software, SaaS, IT consulting, and technology-enabled service businesses.
Deal Track Record and Transaction Statistics
Dresner Partners has completed over $8 billion in aggregate transaction value across 64 documented deals (as of January 2026, per Tracxn). The firm's publicly announced transactions in 2025-2026 include:
- New England Fertility Institute to CSG.Bio (July 2025) - International fertility services platform acquired by life sciences company
- Valley E.N.T. Associates and Masdon ENT & Facial Plastic Surgery to Confluence Healthcare Partners (December 2025) - Multi-state otolaryngology consolidation
- Connoisseurs Products to Willert Home Products (April 2025) - Consumer products; Jewish-family-owned jewelry cleaner brand
- CAI Custom Alloys to EverMetal Holdings (August 2025) - Aerospace materials recycling; backed by PE consortium including GEF Capital Partners
- Therafin Corporation to AltimateMedical (April 2025) - Healthcare partnership transaction
- Sandin Manufacturing to MultiTech Industries (2024) - Materials/industrial deal of the year recognition
The firm's transaction profile reflects 60%+ healthcare emphasis, with strong presence in consumer and industrials. Deal sizes range from $10M-$250M enterprise value, with sweet spot around $25M-$150M.
Process and Fee Structure
Dresner runs institutional-quality sell-side processes tailored to client objectives. The firm conducts extensive buyer research and outreach (100-200+ buyer contacts typical), manages comprehensive data rooms, provides management presentation coaching, and negotiates deal terms that optimize for multiple objectives (not just price). Process timelines typically run 6-9 months from engagement to close, with senior banker involvement throughout.
Fee structure: While Dresner's website does not publicly disclose specific fee terms, industry standard for middle-market M&A advisors is modified Lehman (double Lehman) success fees combined with monthly retainers ($10K-$25K/month range, credited against success fees). Minimum engagement sizes are typically $10M-$15M TEV.
Buyer Network and Strategic Relationships
Through 30+ years in the market, Dresner maintains extensive relationships with:
Private Equity Sponsors: Generalist PE firms (KKR, Bain Capital, Genstar, Audax), sector-focused platforms (GEF Capital Partners for critical infrastructure/climate tech), and lower-middle market PE (which represents majority of Dresner's buyer base)
Strategic Acquirers: Large healthcare systems, consolidators in healthcare services (Confluence Healthcare Partners, CSG.Bio, various IVF platforms), Fortune 500 industrial companies, and family offices with active acquisition programs
International Buyers: Through membership in Mergers Alliance (one of the world's leading global M&A partnerships), Dresner connects middle-market sellers with international strategic buyers and cross-border PE sponsors
Recent deals evidence strong PE relationships—CAI went to a PE-backed platform, Valley E.N.T./Masdon went to Confluence (healthcare consolidator), and New England Fertility went to CSG.Bio (strategic life sciences acquirer).
Competitive Positioning and Differentiation
Dresner's advantages relative to other middle-market banks:
-
Specialization with Scale. Unlike generalist regional banks, Dresner has carved out deep expertise in healthcare and consumer products with 30+ bankers dedicated to these sectors. The healthcare practice alone has closed 50+ transactions.
-
Independent Advisory Model. Absence of investment research, debt underwriting, or proprietary positions means zero conflicts of interest. Dresner works for clients, not for the transaction.
-
Senior Banker Engagement. President Steven Dresner personally oversees major transactions. Senior managing directors like Brian Ytterberg (COO), Paul Hoffman, and Mitchell Stern (healthcare lead) are available for day-to-day leadership, not relegated to one-time meetings.
-
Mergers Alliance Access. Global relationships through Mergers Alliance mean access to European, Asian, and LATAM buyers without developing those relationships independently.
-
Long-Term Relationship Focus. Unlike some banks that operate transactionally, Dresner emphasizes post-close partnership. Testimonials from clients like Dr. Gad Lavy (New England Fertility) emphasize Dresner's hands-on collaboration.
Who Dresner Works Best With
Perfect Fit: Founder-owned middle-market businesses ($25M-$200M TEV) in healthcare, consumer products, business services, or light manufacturing seeking a strategic sale or PE recapitalization. Sellers who value process quality, multiple buyer options, and objective advice from a senior team.
Less Ideal Fit: Businesses below $10M TEV (below Dresner's sweet spot), highly distressed situations requiring immediate sale, or founders seeking a limited/quick process. Dresner's value proposition is maximizing value through thorough process—if speed is paramount, it's not the right fit.
Geographic Coverage and Operations
Dresner Partners operates from eight offices: Chicago (headquarters), New York, Cleveland, San Diego, Houston, Fort Lauderdale, New Jersey, and Palo Alto. The firm is FINRA-registered (CRD# 35145, established 1993) and maintains licenses across 10 US states. Leadership spans geographies—Steven Dresner and Brian Ytterberg lead from Chicago, Paul Hoffman (Chicago) covers industrials, Mitchell Stern (Fort Lauderdale/New Jersey) leads healthcare, Christopher Kampe (Fort Lauderdale) leads consumer, and Matthew Jones (Palo Alto) leads technology.
Team and Credentials
Dresner's senior team brings 100+ years of cumulative investment banking experience. Key team members include:
- Steven M. Dresner (President/Founder) - 30+ years founding and scaling the firm
- Brian V. Ytterberg (Senior Managing Director/COO) - Operational leadership, transaction oversight
- Paul E. Hoffman (Managing Director) - Industrials and materials focus; 50+ transactions
- Mitchell Stern (Managing Director, Healthcare Head) - Deep healthcare services expertise; 40+ healthcare transactions
- Christopher Kampe (Managing Director, Consumer/Retail) - Consumer products specialist
- Matthew Jones (Managing Director, Technology) - Technology and SaaS sector lead
- Christopher Nolan (Managing Director) - New York-based; transaction execution
The team includes individuals with prior roles at Goldman Sachs (Sarah Martinez), Houlihan Lokey, and other top-tier investment banks, combined with sector-specific entrepreneurs and operators. Many team members hold Series 79 (investment banker) registrations and relevant certifications (CFA, CBI, CM&AA).
Awards and Market Recognition
Dresner was named a winner of the 23rd Annual M&A Advisor Awards (2024) for Materials Deal of the Year (Sandin Manufacturing transaction). The firm is recognized in Mergers Alliance as a leading member firm globally, underscoring institutional credibility.
Independence and Integrity
Dresner remains independent (no equity positions, no strategic debt underwriting, no conflicted research). The firm's fee model aligns advisor and client interests—Dresner only makes money when transactions close at prices and terms clients accept. This creates accountability and genuine motivation to maximize value rather than optimize for transaction velocity.